Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation

Kristian Boasman, Matthew James Simmonds, Ciaren Graham, Yogen Saunthararajah, Ciro Roberto Rinaldi

Research output: Contribution to journalArticle

Original languageEnglish
JournalAnnals of Hematology
Early online date05 Feb 2019
DOIs
Publication statusEarly online date - 05 Feb 2019
Externally publishedYes

Cite this

@article{c9d537218fb842829666e619fa2c4b14,
title = "Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation",
author = "Kristian Boasman and Simmonds, {Matthew James} and Ciaren Graham and Yogen Saunthararajah and Rinaldi, {Ciro Roberto}",
year = "2019",
month = "2",
day = "5",
doi = "10.1007/s00277-019-03627-9",
language = "English",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",

}

Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation. / Boasman, Kristian; Simmonds, Matthew James; Graham, Ciaren; Saunthararajah, Yogen; Rinaldi, Ciro Roberto.

In: Annals of Hematology, 05.02.2019.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Using PU.1 and Jun dimerization protein 2 transcription factor expression in myelodysplastic syndromes to predict treatment response and leukaemia transformation

AU - Boasman, Kristian

AU - Simmonds, Matthew James

AU - Graham, Ciaren

AU - Saunthararajah, Yogen

AU - Rinaldi, Ciro Roberto

PY - 2019/2/5

Y1 - 2019/2/5

U2 - 10.1007/s00277-019-03627-9

DO - 10.1007/s00277-019-03627-9

M3 - Article

C2 - 30721335

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

ER -